Edmond de Rothschild (Suisse)’s Juno Therapeutics, Inc. JUNO Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$98K	Buy	3,250 +2,750	+550%	+$85.6K	0.03%	260
2016 Q2	$19K	Sell	500 -500	-50%	-$20.8K	0.01%	359
2016 Q1	$38K	Sell	1,000 -425	-30%	-$14.8K	0.02%	282
2015 Q4	$63K	Buy	1,425 +800	+128%	+$39.7K	0.02%	222
2015 Q3	$25K	Buy	+625	New	+$27.4K	0.01%	330

Other funds holding JUNO

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s JUNO Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) increased its Juno Therapeutics, Inc. (JUNO) stake by 550% in Q3 2016, buying an estimated $85.6K and bringing the position to 3,250 shares worth $98K. The position accounts for 0.03% of the portfolio, ranked #260.

Edmond de Rothschild (Suisse) first reported a position in JUNO in Q3 2015 and has held it in 5 quarters since. 169 funds tracked by Wall St. Rank hold JUNO as of Q3 2016.

Edmond de Rothschild (Suisse) held 3,250 shares of Juno Therapeutics, Inc. worth $98K as of Q3 2016.
Edmond de Rothschild (Suisse) bought 2,750 Juno Therapeutics, Inc. shares in Q3 2016, an estimated $85.6K.
Juno Therapeutics, Inc. made up 0.03% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #260 holding.
Edmond de Rothschild (Suisse) first reported a position in Juno Therapeutics, Inc. in Q3 2015 and has held it in 5 quarters since.
169 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.